Centralized Pan-South African Survey on the Undertreatment of Hypercholesterolaemia
Summary
This is a multi-centre survey of patients who are currently on lipid lowering pharmacological treatment in South Africa.
Study Design
Observational Model: Cohort, Time Perspective: Prospective
Conditions
Undertreatment of Hypercholesterolaemia
Location
Research Site
Johannesburg
South Africa
Status
Recruiting
Source
AstraZeneca
Results (where available)
Links
- Source: http://clinicaltrials.gov/show/NCT01027624
- Information obtained from ClinicalTrials.gov on July 15, 2010
Medical and Biotech [MESH] Definitions
Clinical Trials
The purpose of this study is to compare the effectiveness and safety of rosuvastatin 5mg in lowering blood cholesterol, compared to one other medicine, atorvastatin 10mg in Asian patients...
This study is designed to assess whether colesevelam given as third line treatment added to a maximal tolerated and stable dose of a statin and ezetimibe is able to further decrease the le...
OLE Study to Evaluate Safety / Efficacy of ZD4522
The purpose of this study is to assess the long term safety of Crestor.
Carotid Atorvastatin Study in Hyperlipidemic Post-Menopausal Women
To evaluate the effect of atorvastatin 80 mg, versus placebo, given for 12 months on carotid intima-media thickness in postmenopausal women with moderate hypercholesterolemia.
Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients
This is a single-arm, phase IV, open-label, prospective, non interventional study to evaluate the efficacy, tolerability and safety of rosuvastatin administered for 24 weeks in approximate...
PubMed Articles
Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades.
Background: This study evaluated the effectiveness of long-term intensive lipid-lowering therapy in children and adolescents with familial hypercholesterolaemia. Methods: The charts of 89 children and...
BACKGROUND: Autosomal dominant hypercholesterolaemia is genetically heterogeneous, but most commonly ( approximately 93%) caused by mutations in low-density lipoprotein receptor (LDLR), where the dise...
OBJECTIVE: To determine the optimal cut-offs of BMI for Malaysian adults. DESIGN: Population-based, cross-sectional study. Receiver operating characteristic curves were used to determine the cut-off v...
Familial hypercholesterolaemia (FH) is a dominantly inherited disorder present from birth that causes marked elevation in plasma cholesterol and premature coronary heart disease. It is estimated that...
Lipids: Targeting cascade screening in familial hypercholesterolaemia.